Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide additional valuable insights in to the MedComms business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are.

In this webinar, we’re joined by Jan Seal-Roberts, Publishing Director at Adis, Springer Healthcare. Everyone has heard the term ‘PLS’ – but there still seems to be a lot of confusion about:

* what these are
* who they are intended for
* the ideal reading level
* and which journals accept these.

And that’s before we start talking about the value proposition and why these might be worth the effort!

Last month Jan Seal-Roberts ran a 3-hour workshop on this at ISMPP US, which was attended by a lot of key pharma people from global who were keen to learn more about PLS and how to start taking advantage of the opportunities that these offer. Jan distils this down to a 15-min session to bring everyone up to speed with PLS – and will explain exactly why we should be thinking about including these in our publications. You may be surprised! And we answer questions from the audience.

Recorded 29 May 2019 as a MedComms Networking webinar. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Jan’s Linkedin page is at https://www.linkedin.com/in/jan-seal-roberts-20658914/

More about Adis can be found at https://www.springer.com/gp/adis

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free webcasts and other video content for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new content.

[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]